TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ANL

Adlai Nortye Ltd.

Healthcare · Biotechnology

15.40$ +1.9% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ANL
Line item Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 25 Q1 26 Q2 26
– – – – – – +0.0% -70.2% +0.0% +235.6% +193.6% +0.0%
– – – – +21.2% – – – – – – –
– – – – – – +0.0% -70.2% +0.0% +235.6% +193.6% +0.0%
– +25.2% +0.0% -18.3% +4.7% +10.9% +0.0% -15.8% +0.0% -32.4% -16.8% +0.0%
– -34.0% +0.0% -28.4% +43.4% +63.2% +0.0% -53.1% +0.0% -11.1% +38.7% +0.0%
– +9.7% +0.0% -20.6% +10.5% +19.9% -25.1% -3.4% +0.0% -26.4% -5.0% +0.0%
– – – – – – – – – – – –
– – – – +103.8% +68.4% – – +0.0% -7.9% -49.0% +0.0%
– – – – – – – – – – – –
– – – – -13,771.0% – +0.0% +0.0% – – – –
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?